Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orgenesis Inc (ORGS)
OTHER OTC:ORGS
Holding ORGS?
Track your performance easily
ORGS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.87 - $10.80
Previous CloseN/A
Volume307.00
Average Volume (3M)13.65K
Market Cap
$7.60M
Enterprise Value$37.17M
Total Cash (Recent Filing)$3.52M
Total Debt (Recent Filing)$4.53M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.26
Shares Outstanding5,169,248
10 Day Avg. Volume7,096
30 Day Avg. Volume13,653
Standard Deviation0.28
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)14.34
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap4.89
Enterprise Value/Revenue-2.89
Enterprise Value/Gross Profit-6.49
Enterprise Value/Ebitda-0.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Orgenesis News
PremiumCompany Announcements
Orgenesis Inc. Reports Q3 2024 Financial Results
PremiumCompany Announcements
Orgenesis Expands Board with Three New Appointments
PremiumCompany Announcements
Orgenesis Announces Reverse Stock Split to Maintain Nasdaq ComplianceRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ORGS FAQ
What was Orgenesis Inc’s price range in the past 12 months?
Orgenesis Inc lowest stock price was $0.87 and its highest was $10.80 in the past 12 months.
What is Orgenesis Inc’s market cap?
Orgenesis Inc’s market cap is $7.60M.
When is Orgenesis Inc’s upcoming earnings report date?
Orgenesis Inc’s upcoming earnings report date is Feb 13, 2025 which is in 15 days.
How were Orgenesis Inc’s earnings last quarter?
Orgenesis Inc released its earnings results on Nov 13, 2024. The company reported -$1.93 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.93.
Is Orgenesis Inc overvalued?
According to Wall Street analysts Orgenesis Inc’s price is currently Overvalued.
Does Orgenesis Inc pay dividends?
Orgenesis Inc does not currently pay dividends.
What is Orgenesis Inc’s EPS estimate?
Orgenesis Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orgenesis Inc have?
Orgenesis Inc has 5,169,248 shares outstanding.
What happened to Orgenesis Inc’s price movement after its last earnings report?
Orgenesis Inc reported an EPS of -$1.93 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.167%.
Which hedge fund is a major shareholder of Orgenesis Inc?
Currently, no hedge funds are holding shares in ORGS
---
Company Description
Orgenesis Inc
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CT) segments. The CDMO segment through MaSTherCell, comprises of comprehensive services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The CT segment includes a technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and trans-differentiating them into pancreatic beta cell-like insulin-producing cells. The company was founded on June 5, 2008 by Sarah Ferber and is headquartered in Germantown, MD.
---
Technical Analysis
---